Billiontoone (NASDAQ:BLLN) Insider Sells $1,063,173.54 in Stock

Billiontoone, Inc. (NASDAQ:BLLN) insider Nancy Joann Johnson sold 10,582 shares of Billiontoone stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $100.47, for a total transaction of $1,063,173.54. Following the sale, the insider directly owned 21,900 shares of the company’s stock, valued at $2,200,293. This represents a 32.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Nancy Joann Johnson also recently made the following trade(s):

• On Monday, June 8th, Nancy Joann Johnson sold 3,418 shares of Billiontoone stock. The shares were sold at an average price of $99.28, for a total transaction of $339,339.04.

Billiontoone Trading Down 3.1%

Shares of Billiontoone stock traded down $3.13 on Wednesday, hitting $99.26. 1,040,614 shares of the company traded hands, compared to its average volume of 694,048. The stock’s 50 day moving average price is $87.26 and its 200-day moving average price is $88.18. The company has a debt-to-equity ratio of 0.18, a quick ratio of 10.58 and a current ratio of 10.92. Billiontoone, Inc. has a 52 week low of $61.96 and a 52 week high of $138.70.

Billiontoone (NASDAQ:BLLN) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.33. The company had revenue of $108.39 million for the quarter, compared to the consensus estimate of $95.81 million. During the same period in the prior year, the firm posted ($0.39) EPS. The business’s revenue was up 83.8% on a year-over-year basis. As a group, analysts expect that Billiontoone, Inc. will post 0.93 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. JPMorgan Chase & Co. boosted their price target on shares of Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Guggenheim boosted their price objective on shares of Billiontoone from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. Wall Street Zen raised shares of Billiontoone from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. Weiss Ratings downgraded shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday, June 5th. Finally, Wells Fargo & Company reduced their price objective on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a research note on Thursday, March 5th. Six investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Billiontoone currently has an average rating of “Moderate Buy” and an average price target of $125.29.

Hedge Funds Weigh In On Billiontoone

A number of large investors have recently bought and sold shares of the business. Perceptive Advisors LLC raised its stake in Billiontoone by 26.1% in the first quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock worth $7,248,000 after buying an additional 19,000 shares in the last quarter. Bank of America Corp DE raised its stake in Billiontoone by 8,603.4% in the first quarter. Bank of America Corp DE now owns 12,707 shares of the company’s stock worth $1,003,000 after buying an additional 12,561 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in Billiontoone by 151.8% in the first quarter. The Manufacturers Life Insurance Company now owns 30,506 shares of the company’s stock worth $2,408,000 after buying an additional 18,389 shares in the last quarter. Renaissance Technologies LLC bought a new position in Billiontoone in the first quarter worth approximately $4,046,000. Finally, Public Employees Retirement System of Ohio bought a new position in Billiontoone in the first quarter worth approximately $1,539,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.